PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28663131-2	2017	Here, we compared the levels of Lyso-Gb3 in dried blood spots (DBS) and sera in affected males and heterozygotes with the "Classic" and "Later-Onset" phenotypes.	dbs	63-66	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	37-40	
28663131-3	2017	METHODS: The Lyso-Gb3 concentrations in DBS and sera from 56 FD patients were determined by highly sensitive electrospray ionization liquid chromatography tandem mass spectrometry.	dbs	40-43	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	18-21	
28663131-7	2017	The overall correlation between the Lyso-Gb3 levels in DBS and sera was high (R=0.99; p<0.001).	dbs	55-58	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	41-44	
28663131-8	2017	CONCLUSION: DBS provides a convenient, sensitive, and reproducible source to measure Lyso-Gb3 levels for diagnosis, initial phenotypic assignment, and therapeutic monitoring in patients with Fabry disease.	dbs	12-15	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	90-93	
23109060-8	2013	The DBS lyso-Gb3 level was not elevated in IVS4+919G>A heterozygotes, and is not useful for their diagnosis.	dbs	4-7	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	13-16	
23826564-5	2013	The HPLC-MS/MS method for analysis of lyso-Gb3 is robust and yields reproducible results in DBS in patients with FD.	dbs	92-95	alpha 1,4-galactosyltransferase (P blood group)	Homo sapiens	43-46